1. Pérez-Cabello, Jesús A, Silvera-Carrasco, Lucía, Franco, Jaime M, Pozo, David, Roodveldt, Cintia. 2023. MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2302143120. doi:10.1073/pnas.2302143120. https://pubmed.ncbi.nlm.nih.gov/37399380/
2. Passaro, Antonio, Mok, Tony, Peters, Solange, Ahn, Myung-Ju, de Marinis, Filippo. 2020. Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations. In Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 16, 764-773. doi:10.1016/j.jtho.2020.12.002. https://pubmed.ncbi.nlm.nih.gov/33333327/
3. Qian, Jun, Chen, Qin, Yao, Dong-Ming, Deng, Zhao-Qun, Lin, Jiang. 2015. MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia. In International journal of clinical and experimental pathology, 8, 127-36. doi:. https://pubmed.ncbi.nlm.nih.gov/25755699/
智鼠故事 
